CMS modified NCD 234 governing electrical continence aids, effective January 9, 2026. This device remains non-covered under Medicare — and your billing team needs to know exactly why claims will be denied.
The Centers for Medicare & Medicaid Services updated NCD 234, the National Coverage Determination governing Medicare coverage of electrical continence aids. This coverage policy confirms the device is not covered under Medicare because CMS classifies it as experimental, with no valid scientific documentation of effectiveness or safety. No specific CPT or HCPCS codes are listed in the policy data for this item. What matters for your billing team is the hard non-coverage stance and the medical necessity rationale behind it.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Electrical Continence Aid — NCD 234 |
| Policy Code | NCD 234 |
| Change Type | Modified |
| Effective Date | 2026-01-09 |
| Impact Level | Medium — any team billing for continence devices or pelvic floor therapies should review their charge capture |
| Specialties Affected | Urology, Colorectal Surgery, Physical Medicine & Rehabilitation, DME suppliers |
| Key Action | Do not bill Medicare for electrical continence aids — confirm your charge capture excludes any related codes for this device |
CMS Electrical Continence Aid Coverage Criteria and Medical Necessity Requirements 2026
The CMS electrical continence aid coverage policy under NCD 234 is straightforward: there is no covered indication. CMS denies coverage under §1862(a)(1) of the Social Security Act. That statute requires services to be "reasonable and necessary" for the treatment of an illness or injury — or to improve the functioning of a malformed body member. This device doesn't meet that bar.
The medical necessity argument here isn't about diagnosis codes or prior authorization. CMS goes further upstream and disqualifies the device at the technology level. No amount of documentation or prior auth paperwork changes the outcome. The claim will be denied regardless.
CMS describes the electrical continence aid as a plastic plug molded to fit the patient's anal canal. It contains two implanted electrodes connected by wire to a portable generator. The electrical current stimulates anal musculature to produce a contraction. The intent is to allow ambulation without incontinence. CMS acknowledges the device's mechanical design — and still says no.
The reason is explicit: CMS calls this device experimental. There is no valid scientific documentation of its effectiveness and safety. Until that evidence base changes and CMS issues a new or revised NCD, no Medicare reimbursement is available for this device under any diagnosis.
CMS Electrical Continence Aid Exclusions and Non-Covered Indications
This entire NCD 234 coverage policy is built around a single exclusion. The electrical continence aid is not covered under Medicare, period. There are no covered indications, no coverage-with-evidence-development pathways, and no exceptions listed in the policy.
CMS classifies the device as being in the "experimental stage of development." That language matters. It's not just a coverage limitation — it's a scientific credibility judgment. CMS is saying the evidence doesn't exist yet to establish this device as safe and effective. That's a higher bar than a simple exclusion.
If a patient asks whether Medicare will cover this device, the answer is no. If a provider wants to appeal, they're fighting the experimental classification itself — not a documentation deficiency. That's a very different kind of challenge, and one that belongs with your compliance officer and legal counsel, not your billing team.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Fecal incontinence managed with electrical continence aid | Not Covered | Not listed in policy | Device classified as experimental; denied under §1862(a)(1) |
| Electrical stimulation for anal musculature contraction | Not Covered | Not listed in policy | No valid scientific documentation of effectiveness or safety per CMS |
| Use of portable generator with anal electrode plug | Not Covered | Not listed in policy | Full device system excluded — no partial coverage pathway |
CMS Electrical Continence Aid Billing Guidelines and Action Items 2026
The effective date for this modified policy is January 9, 2026. Here's what to do now.
| # | Action Item |
|---|---|
| 1 | Audit your charge capture for any electrical continence aid codes. If your practice or DME operation has ever billed — or considered billing — for this device, confirm those codes are flagged as non-covered for Medicare. Remove them from any active Medicare fee schedule templates before January 9, 2026. |
| 2 | Check your ABN workflow. If a patient is a Medicare beneficiary and wants this device, you need an Advance Beneficiary Notice of Noncoverage before providing the item. The patient must understand Medicare will not pay. Document that conversation. Electrical continence aid billing without an ABN exposes your organization to liability. |
| 3 | Do not submit claims expecting denial for appeal purposes. Some teams use denial-and-appeal as a strategy to build a record. With an experimental classification under NCD 234, that strategy wastes time and creates audit risk. CMS has no covered pathway here. Skip the claim submission entirely for Medicare patients unless you have a signed ABN and the patient agrees to pay out of pocket. |
| 4 | Review your commercial and Medicaid payer contracts separately. This NCD 234 update applies to Medicare only. Your commercial payers — Aetna, Cigna, UnitedHealthcare — may have different coverage policies for this device. Check each payer's specific coverage policy before assuming non-coverage across the board. |
| 5 | Train your patient-facing staff on the non-coverage language. Front desk and billing teams need to understand why this device isn't covered. "It's experimental" is the correct answer. Patients who push back should be directed to their provider for a conversation about the evidence gap — not to your billing team for an appeal. |
| 6 | If your organization is involved in clinical trials for continence devices, loop in your compliance officer now. Investigational device exemptions and coverage-with-evidence-development pathways have specific billing rules. The standard NCD 234 non-coverage determination doesn't automatically block coverage in a clinical trial context — but the rules are complex. Don't assume. Talk to your compliance officer before billing any Medicare claim related to a trial involving this device. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Electrical Continence Aid Under NCD 234
A Note on Code Availability
The NCD 234 policy data does not list specific CPT, HCPCS Level II, or ICD-10-CM codes. This is common for older NCDs covering experimental devices — CMS often issues the non-coverage determination without assigning billing codes because the device was never approved for routine billing in the first place.
The absence of codes isn't a gap you can work around. It means there is no recognized billing code path for Medicare reimbursement of this device. If your DME supplier or specialty practice has assigned an internal code for this item, that code has no Medicare reimbursement pathway under NCD 234.
What This Means for Your Billing Team
No codes appear in the policy data for NCD 234. Do not attempt to map this device to adjacent HCPCS codes for similar continence or pelvic floor devices — that's unbundling risk and potentially fraudulent billing. If you're unsure whether a code your team uses might fall under this NCD's scope, bring that question to your compliance officer before the January 9, 2026 effective date.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.